[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 25, 2006

Biomedical Patents and the Public's HealthIs There a Role for Eminent Domain?

Author Affiliations

Author Affiliations: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

JAMA. 2006;295(4):434-437. doi:10.1001/jama.295.4.434

As a government-sanctioned monopoly, a drug patent allows its owner to prevent others from making, using, or selling a given medication for a set amount of time. Patents can help encourage and reward scientific innovation in the pharmaceutical industry. But some drug companies have been criticized for restricting access to products in the face of actual or potential public health emergencies1 or distorting the patent system in pursuit of higher revenues.2

First Page Preview View Large
First page PDF preview
First page PDF preview